Science Explorer Back to mapMap
Discussion
Company · Stockholm · Sweden

Swedish Orphan Biovitrum (Sweden)

In research, Swedish Orphan Biovitrum (Sweden) stands highest in Life Sciences (#7,880 of 11,023 worldwide), Health Sciences (#12,100 of 16,688 worldwide) and Medicine (#10,854 of 14,558 worldwide), over all time.

World rank, all time
#25,998
of 34,923
Rank in Sweden
#189
of 259
Research works
424
▲ 5% vs 2018-21
Citations
13k
29.5 per fractional work
Top-10% rate
12.5%
all institutions 10.0%
vs its own fields
0.93×
1.00× is exactly expected
Open access
31%
world 40%
International
27%
world 18%

What is Swedish Orphan Biovitrum (Sweden) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Life SciencesDomain #7,880 of 11,023 6.8%158
Health SciencesDomain #12,100 of 16,688 9.9%188
MedicineField #10,854 of 14,558 10.2%178

Each strip is that field's whole ranked pool, with the notch where Swedish Orphan Biovitrum (Sweden) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Swedish Orphan Biovitrum (Sweden) work in?

In 2022-now, 68% of research at Swedish Orphan Biovitrum (Sweden) is in Health Sciences, 17% in Life Sciences. Its largest fields are Medicine (68%), Immunology and Microbiology (11%), Engineering (7%). It does 2.5× the world's share of Health Sciences.

Health Sciences: 34 fractional works · 68.4% of its workMedicine: 34 fractional works · 68.2% of its workHematology: 11 fractional works · 22.7% of its workGenetics: 4 fractional works · 8.7% of its workNephrology: 3 fractional works · 5.6% of its workPulmonary and Respiratory Medicine: 3 fractional works · 5.3% of its workSurgery: 2 fractional works · 3.8% of its workOncology: 2 fractional works · 3.0% of its workRheumatology: 1 fractional works · 2.2% of its workBiochemistry: 1 fractional works · 2.1% of its workHepatology: 1 fractional works · 2.0% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.7% of its workPathology and Forensic Medicine: 1 fractional works · 1.7% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.1% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.9% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.7% of its workPhysiology: 0 fractional works · 0.7% of its workImmunology and Allergy: 0 fractional works · 0.7% of its workTransplantation: 0 fractional works · 0.6% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.6% of its workEpidemiology: 0 fractional works · 0.5% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.5% of its workUrology: 0 fractional works · 0.4% of its workNeurology: 0 fractional works · 0.4% of its workOtorhinolaryngology: 0 fractional works · 0.4% of its workPsychiatry and Mental health: 0 fractional works · 0.3% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.2% of its workFamily Practice: 0 fractional works · 0.2% of its workInfectious Diseases: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.9% of its workHealth Professions: 0 fractional works · 0.2% of its workLife Sciences: 8 fractional works · 17.0% of its workImmunology and Microbiology: 5 fractional works · 10.5% of its workImmunology: 5 fractional works · 10.5% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 6.1% of its workMolecular Biology: 2 fractional works · 4.8% of its workPhysiology: 0 fractional works · 0.5% of its workGenetics: 0 fractional works · 0.3% of its workCancer Research: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workNeuroscience: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.0% of its workPhysical Sciences: 5 fractional works · 10.9% of its workEngineering: 3 fractional works · 7.1% of its workBiomedical Engineering: 2 fractional works · 4.0% of its workMechanical Engineering: 1 fractional works · 2.4% of its workSafety, Risk, Reliability and Quality: 0 fractional works · 0.4% of its workAutomotive Engineering: 0 fractional works · 0.2% of its workEnvironmental Science: 1 fractional works · 1.1% of its workGlobal and Planetary Change: 0 fractional works · 0.7% of its workEcological Modeling: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEnergy: 0 fractional works · 0.9% of its workGeneral Energy: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.2% of its workComputer Science: 0 fractional works · 0.8% of its workInformation Systems: 0 fractional works · 0.4% of its workComputational Theory and Mathematics: 0 fractional works · 0.3% of its workChemistry: 0 fractional works · 0.6% of its workAnalytical Chemistry: 0 fractional works · 0.3% of its workSpectroscopy: 0 fractional works · 0.2% of its workMaterials Science: 0 fractional works · 0.2% of its workBiomaterials: 0 fractional works · 0.2% of its workPhysics and Astronomy: 0 fractional works · 0.2% of its workRadiation: 0 fractional works · 0.2% of its workChemical Engineering: 0 fractional works · 0.1% of its workSocial Sciences: 2 fractional works · 3.7% of its workSocial Sciences: 1 fractional works · 1.3% of its workSociology and Political Science: 1 fractional works · 1.3% of its workBusiness, Management and Accounting: 0 fractional works · 0.7% of its workManagement of Technology and Innovation: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workDecision Sciences: 0 fractional works · 0.7% of its workStatistics, Probability and Uncertainty: 0 fractional works · 0.4% of its workInformation Systems and Management: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.6% of its workEconomics and Econometrics: 0 fractional works · 0.6% of its workPsychology: 0 fractional works · 0.4% of its workDevelopmental and Educational Psychology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workALL ITS WORKSwedish OrphanBiovitrum…49fractional works, 2022-now
Life Sciences17%Physical Sciences11%Health Sciences68%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 20 fields, with their numbers
    1. Medicine3468.2%
    2. Health Professions00.2%
    1. Immunology and Microbiology510.5%
    2. Biochemistry, Genetics and Molecular Biology36.1%
    3. Neuroscience00.2%
    4. Agricultural and Biological Sciences00.1%
    5. Pharmacology, Toxicology and Pharmaceutics00.0%
    1. Engineering37.1%
    2. Environmental Science11.1%
    3. Energy00.9%
    4. Computer Science00.8%
    5. Chemistry00.6%
    6. Materials Science00.2%
    7. Physics and Astronomy00.2%
    8. Chemical Engineering00.1%
    1. Social Sciences11.3%
    2. Business, Management and Accounting00.7%
    3. Decision Sciences00.7%
    4. Economics, Econometrics and Finance00.6%
    5. Psychology00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.03× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.15× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 10.45× its world share, 5 worksImmunology and Micro…Neuroscience: 0.10× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.09× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 0.28× its world share, 0 worksChemical EngineeringChemistry: 0.36× its world share, 0 worksChemistryComputer Science: 0.10× its world share, 0 worksComputer ScienceEnergy: 0.95× its world share, 0 worksEnergyEngineering: 0.47× its world share, 4 worksEngineeringEnvironmental Science: 0.21× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.06× its world share, 0 worksMaterials SciencePhysics and Astronomy: 0.10× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.06× its world share, 0 worksHealth ProfessionsMedicine: 3.55× its world share, 34 worksMedicineBusiness, Management and Accounting: 0.23× its world share, 0 worksBusiness, Management…Decision Sciences: 0.70× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.27× its world share, 0 worksEconomics, Econometr…Psychology: 0.14× its world share, 0 worksPsychologySocial Sciences: 0.10× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 10.4×. Every wedge is a field page.

All 20 fields, with their numbers
  1. Immunology and Microbiology10.45×5 works
  2. Medicine3.55×34 works
  3. Biochemistry, Genetics and Molecular Biology1.15×3 works
  4. Energy0.95×0 works
  5. Decision Sciences0.70×0 works
  6. Engineering0.47×4 works
  7. Chemistry0.36×0 works
  8. Chemical Engineering0.28×0 works
  9. Economics, Econometrics and Finance0.27×0 works
  10. Business, Management and Accounting0.23×0 works
  11. Environmental Science0.21×0 works
  12. Psychology0.14×0 works
  13. Neuroscience0.10×0 works
  14. Computer Science0.10×0 works
  15. Physics and Astronomy0.10×0 works
  16. Social Sciences0.10×1 works
  17. Pharmacology, Toxicology and Pharmaceutics0.09×0 works
  18. Materials Science0.06×0 works
  19. Health Professions0.06×0 works
  20. Agricultural and Biological Sciences0.03×0 works

Who are the top researchers at Swedish Orphan Biovitrum (Sweden)?

Ranked on the quality score, Anna Skottner, Bent Winding and Jonas Uppenberg lead among researchers whose main affiliation is Swedish Orphan Biovitrum (Sweden).

  1. 1 Anna Skottner Sweden · #1,297,903 worldwide 4.4k citations · 91 works
  2. 2 Bent Winding Sweden · #1,334,756 worldwide 1.3k citations · 36 works
  3. 3 Jonas Uppenberg Sweden · #1,468,270 worldwide 2.8k citations · 52 works
  4. 4 E. Holmer Sweden · #1,626,793 worldwide 2.1k citations · 46 works
  5. 5 Johan Szamosi Sweden · #1,792,695 worldwide 1.3k citations · 56 works
  6. 6 Carly Rich Sweden · #2,121,279 worldwide 956 citations · 26 works
  7. 7 Linda Fryklund Sweden · #2,163,837 worldwide 3.2k citations · 91 works
  8. 8 Kurt Benkestock Sweden · #2,209,562 worldwide 653 citations · 22 works
  9. 9 L.-O. Andersson Sweden · #2,228,826 worldwide 1.5k citations · 41 works
  10. 10 H Sandberg Sweden · #2,244,817 worldwide 743 citations · 17 works
All ranked researchers at Swedish Orphan Biovitrum (Sweden)

What are the most cited papers from Swedish Orphan Biovitrum (Sweden)?

The most cited paper from Swedish Orphan Biovitrum (Sweden) is "Patient reported outcome measures in practice" (Eugene C. Nelson, Elena Eftimovska, Cristin Lind et al., 2015), with 786 citations. Next come "Reverse ELISPOT assay for clonal analysis of cytokine production I. Enumeration of gamma-interferon-secreting cells" (497) and "In vitro models for the blood–brain barrier" (399).

Most cited papers
#PaperReleasedCitations
1 Patient reported outcome measures in practice Eugene C. Nelson, Elena Eftimovska, Cristin Lind et al. · BMJ Open access 10 Feb 2015 786
2 Reverse ELISPOT assay for clonal analysis of cytokine production I. Enumeration of gamma-interferon-secreting cells Cecil C. Czerkinsky, Gudrun Andersson, Hans-Peter T. Ekre et al. · Journal of Immunological Methods May 1988 497
3 In vitro models for the blood–brain barrier Per Garberg, Marguerite Ball, Natalia Borg et al. · Toxicology in Vitro 27 Aug 2004 399
4 LEKTI Fragments Specifically Inhibit KLK5, KLK7, and KLK14 and Control Desquamation through a pH-dependent Interaction Céline Deraison, Chrystelle Bonnart, Frédéric Lopez et al. · Molecular Biology of the Cell Open access 28 Jun 2007 326
5 Regulation by Growth Hormone of Number of Chondrocytes Containing IGF-I in Rat Growth Plate Anders Nilsson, Jörgen Isgaard, Anders H. Lindahl et al. · Science Aug 1986 319
All 60 most cited papers, with filters and sorting

Which keywords describe research at Swedish Orphan Biovitrum (Sweden)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Gene Therapy, Prophylaxis, Factor VIII, Hemophilia, Inflammation, Genetics, Innate Immunity and Complement.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation6▲ 5.4×18 topics
  2. Gene Therapy6▲ 58×4 topics
  3. Factor VIII5▲ 725×1 topic
  4. Hemophilia5▲ 725×1 topic
  5. Prophylaxis5▲ 85×2 topics
  6. Genetics5▲ 13×4 topics
  7. Innate Immunity4▲ 28×2 topics
  8. Complement4▲ 494×1 topic
  9. Immune4▲ 494×1 topic
  10. Thrombosis4▲ 29×4 topics
  11. Anemia4▲ 76×3 topics
  12. Epidemiology3▲ 1.74×20 topics
  13. Hemostasis3▲ 60×3 topics
  14. Endothelial Dysfunction2▲ 22×3 topics
  15. Pancreatic Cancer2▲ 48×2 topics
  16. Alloimmunization2▲ 199×1 topic
  17. Blood Groups2▲ 199×1 topic
  18. Hereditary Angioedema2▲ 227×1 topic
  19. Kinin Receptor Family2▲ 227×1 topic
  20. Pulmonary Hypertension2▲ 31×2 topics
  21. Cardiovascular Risk2▲ 11×3 topics
  22. Hypertension2▲ 11×3 topics
  23. Immune Thrombocytopenic Purpura2▲ 121×1 topic
  24. Metabolic Syndrome2▲ 4.1×5 topics
  25. Platelets2▲ 45×1 topic
  26. Treatment Guidelines2▲ 15×5 topics
  27. Chronic Kidney Disease1▲ 11×6 topics
  28. Hyperuricemia1▲ 117×1 topic
  29. Uric Acid1▲ 150×1 topic
  30. Blood Transfusion1▲ 59×2 topics
  31. Glomerular Diseases1▲ 75×1 topic
  32. Nephrotic Syndrome1▲ 75×1 topic
  33. Coagulopathy1▲ 27×2 topics
  34. Critical Care1▲ 8.8×2 topics
  35. Hemorrhage1▲ 33×2 topics
  36. Monoclonal Antibodies1▲ 24×3 topics
  37. Sickle-cell Disease1▲ 54×1 topic
  38. Thalassemia1▲ 54×1 topic
  39. Right Heart Assessment1▲ 52×1 topic
  40. Therapeutic Antibodies1▲ 30×2 topics

Which research topics does Swedish Orphan Biovitrum (Sweden) publish most on?

By volume in 2022-now: Hemophilia Treatment and Research, Complement system in diseases, Blood groups and transfusion and Coagulation, Bradykinin, Polyphosphates, and Angioedema.

  1. 1 Hemophilia Treatment and Research Hematology 5 works
  2. 2 Complement system in diseases Immunology 4 works
  3. 3 Blood groups and transfusion Hematology 2 works
  4. 4 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 2 works
  5. 5 Platelet Disorders and Treatments Hematology 2 works
  6. 6 Gout, Hyperuricemia, Uric Acid Nephrology 1 works
  7. 7 Renal Diseases and Glomerulopathies Nephrology 1 works
  8. 8 Hemoglobinopathies and Related Disorders Genetics 1 works
  9. 9 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 1 works
  10. 10 Liver Disease and Transplantation Hepatology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.8%not open69.2%

World: 40% of research is openly available.

with international co-authors27.1%domestic only72.9%

World: 18% is written across borders.

How has Swedish Orphan Biovitrum (Sweden)'s research output changed?

Output in 2022-2025 was 5% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Swedish Orphan Biovitrum (Sweden) as a percentage of every work published that year, 0.00025% in 2024.

still counting0.0020%0.0040%0.0060%Swedish Orphan Biovitrum (Sweden)0.00019% in 202519801990200020102020

Fractional works of Swedish Orphan Biovitrum (Sweden) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Stockholm

All research institutions in Stockholm

Share Swedish Orphan Biovitrum (Sweden)'s ranking

Swedish Orphan Biovitrum (Sweden) on Science Explorer

A card with Swedish Orphan Biovitrum (Sweden)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Swedish Orphan Biovitrum (Sweden). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.